Ethos Technologies LIFE
NASDAQ LIFE
$39.10 -0.62 (-1.55%)
As of: Sep 10, 2026 · 11:38 AM EDT

Ethos Technologies (LIFE) EBITDA (2025 - 2026)

Ethos Technologies (LIFE) posted EBITDA of $18.1 million for Q2 2026, up 111.09% on a QoQ basis from -$163.3 million in Q1 2026, and down 3.84% year-over-year from $18.8 million in Q2 2025.

Analysis

Ethos Technologies (LIFE) EBITDA (2025 - 2026) Analysis & Trends

Ethos Technologies has reported EBITDA for 2 years, with the latest figure at $18.1 million in Q2 2026.

  • On a quarterly basis, EBITDA fell 3.84% year-over-year to $18.1 million in Q2 2026; TTM through Jun 2026 was -$113.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $72.9 million, up 49.59% from the prior year.
  • EBITDA was $18.1 million for Q2 2026 at Ethos Technologies, up from -$163.3 million in the prior quarter.
  • The five-year high for EBITDA was $18.8 million in Q2 2025, with the low at -$163.3 million in Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Hinge Health 7.14 Bn 6.75 Bn 183.95 Mn 40.44 Mn
2 Hims & Hers Health 6.46 Bn 5.62 Bn 480.80 Mn -97.19 Mn
3 Ethos Technologies 2.48 Bn 2.31 Bn 185.54 Mn 18.12 Mn
4 Omada Health 1.31 Bn 1.09 Bn 63.79 Mn 3.55 Mn
5 Teladoc Health 1.12 Bn 346.20 Mn 416.09 Mn -37.09 Mn
6 Talkspace 870.58 Mn 779.48 Mn 24.80 Mn -2.11 Mn
7 Akso Health 232.27 Mn 232.10 Mn - -
8 LifeMD 140.74 Mn 140.74 Mn - -
9 eHealth 29.80 Mn -71.25 Mn - -27.46 Mn
10 Mangoceuticals 6.63 Mn 6.38 Mn 44,215.00 -1.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.12 Mn
Mar 31, 2026 -163.31 Mn
Jun 30, 2025 18.84 Mn
Mar 31, 2025 12.54 Mn